{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T16:03:32Z","timestamp":1784736212423,"version":"3.55.0"},"reference-count":16,"publisher":"American Medical Association (AMA)","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"abstract":"\n Importance<\/jats:title>\n Concerns regarding weight changes during hormonal contraceptive use may influence health care\u2013seeking behavior and contraceptive use patterns. While semaglutide use for weight management has increased substantially among women of reproductive age, the association of hormonal contraception use with semaglutide initiation remains unexplored.<\/jats:p>\n <\/jats:sec>\n \n Objective<\/jats:title>\n To investigate the association between hormonal contraception use and subsequent initiation of semaglutide therapy among females of reproductive age.<\/jats:p>\n <\/jats:sec>\n \n Design, Setting, and Participants<\/jats:title>\n This nested case-control study used Danish health registers to identify all females aged 12 to 49 years from January 1, 1996, to December 31, 2023. Eligible participants included females who filled their first prescription for semaglutide with no prior fill of prescriptions for drugs to lower glucose levels (semaglutide users). The date of first semaglutide prescription fill was the index date. Semaglutide users were each matched by birth year to 10 nonusers (nonuser controls) with no prior use of drugs to lower glucose levels. Data were analyzed from November 25, 2025, to May 18, 2026.<\/jats:p>\n <\/jats:sec>\n \n Exposure<\/jats:title>\n Hormonal contraception use was summarized based on the chronological order of all hormonal contraceptives for which individuals had filled prescriptions from 12 years of age (or study entry) until the index date.<\/jats:p>\n <\/jats:sec>\n \n Main Outcome and Measure<\/jats:title>\n First filled prescription of semaglutide of any dose.<\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n A total of 22\u202f694 cases and 229\u202f640 matched controls (249 634 participants; median age, 37 [IQR, 30-44] years) were included in the analysis. All hormonal contraception utilization patterns were associated with semaglutide initiation compared with nonuser controls. Among utilization patterns involving a single contraceptive type, adjusted hazard ratios ranged from 1.42 (95% CI, 1.34-1.51) for combined oral tablets to 1.63 (95% CI, 1.46-1.82) for progestin-only intrauterine devices. For utilization patterns involving 2 or more contraceptive types, adjusted hazard ratios ranged from 1.64 (95% CI, 1.47-1.82) for combined oral tablets followed by progestin-only oral tablets to 2.11 (95% CI, 1.97-2.25) for other utilization patterns. Adjustment for body mass index attenuated but did not eliminate associations. Subgroup analyses by age, educational attainment, income, parity, immigrant status, and semaglutide type showed consistent associations across most utilization patterns.<\/jats:p>\n <\/jats:sec>\n \n Conclusions and Relevance<\/jats:title>\n In this nationwide case-control study, use of hormonal contraception was associated with subsequent semaglutide initiation across all utilization patterns compared with controls, highlighting a need to examine factors associated with weight management in females.<\/jats:p>\n <\/jats:sec>","DOI":"10.1001\/jamanetworkopen.2026.24382","type":"journal-article","created":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T15:30:26Z","timestamp":1784734226000},"page":"e2624382","source":"Crossref","is-referenced-by-count":0,"title":["Hormonal Contraception and Initiation of Semaglutide Therapy"],"prefix":"10.1001","volume":"9","author":[{"given":"Mille Dybdal","family":"Bager","sequence":"first","affiliation":[{"name":"Copenhagen University Hospital, Steno Diabetes Center Copenhagen, Herlev, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah Karin","family":"Wood-Kurland","sequence":"additional","affiliation":[{"name":"Copenhagen University Hospital, Steno Diabetes Center Copenhagen, Herlev, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathrine Kold","family":"S\u00f8rensen","sequence":"additional","affiliation":[{"name":"Copenhagen University Hospital, Steno Diabetes Center Copenhagen, Herlev, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristian Hay","family":"Kragholm","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Aalborg University Hospital, Aalborg, Denmark"},{"name":"Department of Clinical Medicine, Aalborg University, Aalborg, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikkel Porsborg","family":"Andersen","sequence":"additional","affiliation":[{"name":"Copenhagen University Hospital, Steno Diabetes Center Copenhagen, Herlev, Denmark"},{"name":"The Prehospital Center, Region Zealand, N\u00e6stved, Denmark"},{"name":"Department of Health Science and Technology, Aalborg University, Aalborg, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Torp-Pedersen","sequence":"additional","affiliation":[{"name":"Copenhagen University Hospital, Steno Diabetes Center Copenhagen, Herlev, Denmark"},{"name":"Section of Biostatistics, Department of Public Health, University of Copenhagen, Copenhagen, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Puriya Daniel","family":"W\u00fcrtz Yazdanfard","sequence":"additional","affiliation":[{"name":"Copenhagen University Hospital, Steno Diabetes Center Copenhagen, Herlev, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2026,7,22]]},"reference":[{"issue":"1","key":"zoi260687r1","article-title":"Combination contraceptives: effects on weight.","volume":"2014","author":"Gallo","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"issue":"8","key":"zoi260687r2","article-title":"Progestin-only contraceptives: effects on weight.","volume":"2016","author":"Lopez","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"issue":"4","key":"zoi260687r3","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1097\/AOG.0000000000005712","article-title":"Body mass index changes among adolescents and young adults using the etonogestrel contraceptive implant.","volume":"144","author":"Wernick","year":"2024","journal-title":"Obstet Gynecol"},{"issue":"1","key":"zoi260687r4","first-page":"25","article-title":"Comparison of body weight among hormonal and non-hormonal users in a Malaysian cohort.","volume":"14","author":"Ibrahim","year":"2018","journal-title":"J Taibah Univ Med Sci"},{"issue":"1","key":"zoi260687r5","doi-asserted-by":"publisher","first-page":"48.e1","DOI":"10.1016\/j.ajog.2012.10.876","article-title":"Validity of perceived weight gain in women using long-acting reversible contraception and depot medroxyprogesterone acetate.","volume":"208","author":"Nault","year":"2013","journal-title":"Am J Obstet Gynecol"},{"key":"zoi260687r6","doi-asserted-by":"publisher","first-page":"307","DOI":"10.2147\/CLEP.S456170","article-title":"Semaglutide (Ozempic\u00ae) use in Denmark 2018 through 2023\u2014user trends and off-label prescribing for weight loss.","volume":"16","author":"Mailhac","year":"2024","journal-title":"Clin Epidemiol"},{"issue":"10","key":"zoi260687r7","doi-asserted-by":"publisher","first-page":"1834","DOI":"10.2337\/dc24-1082","article-title":"Real-world use of semaglutide for weight management: patient characteristics and dose titration\u2014a Danish cohort study.","volume":"47","author":"Ladebo","year":"2024","journal-title":"Diabetes Care"},{"key":"zoi260687r8","doi-asserted-by":"publisher","DOI":"10.1016\/j.lanepe.2025.101398","article-title":"Association between socioeconomic factors and semaglutide use for weight loss: a population-based cross-sectional study in Denmark.","volume":"56","author":"Hasselbalch","year":"2025","journal-title":"Lancet Reg Health Eur"},{"key":"zoi260687r9","doi-asserted-by":"publisher","first-page":"469","DOI":"10.2147\/CLEP.S245060","article-title":"Existing data sources in clinical epidemiology: laboratory information system databases in Denmark.","volume":"12","author":"Arendt","year":"2020","journal-title":"Clin Epidemiol"},{"issue":"7","key":"zoi260687r10","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1177\/1403494810394717","article-title":"The Danish National Prescription Registry.","volume":"39","author":"Kildemoes","year":"2011","journal-title":"Scand J Public Health"},{"issue":"2","key":"zoi260687r11","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1093\/oxfordjournals.aje.a009786","article-title":"Factors influencing the optimal control-to-case ratio in matched case-control studies.","volume":"149","author":"Hennessy","year":"1999","journal-title":"Am J Epidemiol"},{"issue":"12","key":"zoi260687r12","doi-asserted-by":"publisher","first-page":"1805","DOI":"10.1007\/s00228-021-03188-9","article-title":"Pharmacoepidemiological methods for computing the duration of pharmacological prescriptions using secondary data sources.","volume":"77","author":"Meaidi","year":"2021","journal-title":"Eur J Clin Pharmacol"},{"issue":"3","key":"zoi260687r13","first-page":"320","article-title":"The Danish Medical Birth Registry.","volume":"45","author":"Knudsen","year":"1998","journal-title":"Dan Med Bull"},{"issue":"7","key":"zoi260687r14","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1177\/1403494810394715","article-title":"Danish education registers.","volume":"39","author":"Jensen","year":"2011","journal-title":"Scand J Public Health"},{"issue":"7","key":"zoi260687r15","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1177\/1403494811405098","article-title":"Danish registers on personal income and transfer payments.","volume":"39","author":"Baadsgaard","year":"2011","journal-title":"Scand J Public Health"},{"issue":"7","key":"zoi260687r16","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1177\/1403494810387965","article-title":"The Danish Civil Registration System.","volume":"39","author":"Pedersen","year":"2011","journal-title":"Scand J Public Health"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2851933\/bager_2026_oi_260687_1784140100.22403.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T15:30:27Z","timestamp":1784734227000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2851933"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,22]]},"references-count":16,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2026.24382","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,22]]}}}